» Articles » PMID: 34993861

Patient Perspectives on Improving Patient-Provider Relationships and Provider Communication During Opioid Tapering

Overview
Publisher Springer
Specialty General Medicine
Date 2022 Jan 7
PMID 34993861
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Efforts to reduce opioid overdose fatalities have resulted in tapering (i.e., reducing or discontinuing) opioid prescriptions despite a limited understanding of patients' experiences.

Objective: To explore patients' perspectives on opioid taper experiences to ultimately improve taper processes and outcomes.

Design: Qualitative study.

Participants: Patients on long-term opioid therapy for chronic pain who had undergone a reduction of opioid daily prescribed dosage of ≥50% in the past 2 years in two distinct medical systems and regions.

Approach: From 2019 to 2020, we conducted semi-structured interviews that were audio-recorded, transcribed, systematically coded, and analyzed to summarize the content and identify key themes regarding taper experiences overall and with particular attention to patient-provider relationships and provider communication during tapers.

Key Results: Participants (n=41) had lived with chronic pain for an average of 17.4 years (range, 3-36 years) and described generally adverse experiences with opioid tapers, the initiation of which was not always adequately justified or explained to them. Consequences of tapers ranged from minor to substantial and included withdrawal, mobility issues, emotional distress, exacerbated mental health symptoms, and feelings of social stigmatization for which adequate supports were typically unavailable. Narratives highlighted the consequential role of patient-provider relationships throughout taper experiences, with most participants describing significant interpersonal challenges including poor provider communication and limited patient engagement in decision making. A few participants identified qualities of providers, relationships, and communication that fostered more positive taper experiences and outcomes.

Conclusions: From patients' perspectives, opioid tapers can produce significant physical, emotional, and social consequences, sometimes reducing trust and engagement in healthcare. Patient-provider relationships and communication influence patients' perceptions of the quality and outcomes of opioid tapers. To improve patients' experiences of opioid tapers, tapering plans should be based on individualized risk-benefit assessments and involve patient-centered approaches and improved provider communication.

Citing Articles

Care Models to Improve Pain and Reduce Opioids Among Patients Prescribed Long-Term Opioid Therapy: The VOICE Randomized Clinical Trial.

Krebs E, Becker W, Nelson D, DeRonne B, Jensen A, Kats A JAMA Intern Med. 2024; 185(2):208-220.

PMID: 39652356 PMC: 11791716. DOI: 10.1001/jamainternmed.2024.6683.


A qualitative exploration of health care workers' approaches to relational harm reduction in HIV primary care settings.

Kay E, Creasy S, Townsend J, Hawk M Harm Reduct J. 2024; 21(1):97.

PMID: 38760824 PMC: 11100089. DOI: 10.1186/s12954-024-01021-x.


A Qualitative Exploration of Providers' Approaches to Relational Harm Reduction in HIV Primary Care Settings.

Kay E, Creasy S, Townsend J, Hawk M Res Sq. 2024; .

PMID: 38586007 PMC: 10996796. DOI: 10.21203/rs.3.rs-4172083/v1.


Disparities in access but not outcomes: Medicaid versus non-Medicaid patients in multidisciplinary chronic pain rehabilitation.

Crouch T, Wedin S, Kilpatrick R, Smith A, Flores B, Rodes J Disabil Rehabil. 2024; 46(25):6114-6121.

PMID: 38411127 PMC: 11347721. DOI: 10.1080/09638288.2024.2321326.


Patient Experiences and Clinical Outcomes in a Multidisciplinary Perioperative Transitional Pain Service.

Manoharan D, Xie A, Hsu Y, Flynn H, Beiene Z, Giagtzis A J Pers Med. 2024; 14(1).

PMID: 38248732 PMC: 10821325. DOI: 10.3390/jpm14010031.


References
1.
Roper K, Jones J, Rowland C, Thomas-Eapen N, Cardarelli R . Mixed Methods Study of Patient and Primary Care Provider Perceptions of Chronic Pain Treatment. Patient Educ Couns. 2020; 104(3):585-594. PMC: 7921200. DOI: 10.1016/j.pec.2020.08.038. View

2.
Dowell D, Haegerich T, Chou R . CDC Guideline for Prescribing Opioids for Chronic Pain--United States, 2016. JAMA. 2016; 315(15):1624-45. PMC: 6390846. DOI: 10.1001/jama.2016.1464. View

3.
Krebs E, Gravely A, Nugent S, Jensen A, DeRonne B, Goldsmith E . Effect of Opioid vs Nonopioid Medications on Pain-Related Function in Patients With Chronic Back Pain or Hip or Knee Osteoarthritis Pain: The SPACE Randomized Clinical Trial. JAMA. 2018; 319(9):872-882. PMC: 5885909. DOI: 10.1001/jama.2018.0899. View

4.
Davis B, Archambault C, Davis K, Oagley C, Schneider J, Kennedy A . A patient-centered approach to tapering opioids. J Fam Pract. 2019; 68(10):548-556. View

5.
Chou R, Fanciullo G, Fine P, Adler J, Ballantyne J, Davies P . Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain. 2009; 10(2):113-30. PMC: 4043401. DOI: 10.1016/j.jpain.2008.10.008. View